1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Real-time Estimate Cboe BZX  -  05/16 10:31:01 am EDT
139.31 USD   +1.02%
05/13MODERNA, INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)
AQ
05/13SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
05/13KHF Welcomes the African Medicines Agency Treaty Cabinet Approval
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna says aims to name 'country of choice' for COVID vaccine production in Africa soon

01/20/2022 | 11:43am EDT

WASHINGTON, Jan 20 (Reuters) - U.S. pharmaceutical company Moderna expects to announce where it will set up a "fill-finish" facility for COVID-19 vaccine production in Africa in the next month or so, its chief legal officer, Shannon Klinger said on Thursday.

Klinger told a virtual event hosted by the Financial Times that the pharmaceutical industry had initially been slow in getting vaccines to Africa, but Moderna now was taking steps to change the situation.

"In terms of timing, we can do fill-finish on the continent as early as next year, and are in active discussions with respect to that. We hope to announce our country of choice in the next month or so," she said.

(Reporting by Andrea Shalal; Editing by Chizu Nomiyama)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
DOW JONES AFRICA TITANS 50 INDEX 1.07% 503.34 Real-time Quote.-7.16%
MODERNA, INC. 1.09% 139.535 Delayed Quote.-45.70%
S&P AFRICA 40 INDEX 1.12% 160.79 Real-time Quote.-9.14%
All news about MODERNA, INC.
05/13MODERNA, INC. Change in Directors or Principal Officers, Financial Statements and Exhi..
AQ
05/13SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
05/13KHF Welcomes the African Medicines Agency Treaty Cabinet Approval
AQ
05/13Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds
MT
05/13Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years
MT
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/13Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds
RE
05/12MARKETSCREENER’S WORLD PRESS REVIEW : May 12, 2022
05/12Moderna CFO exits firm a day after taking charge as probe launched
AQ
05/11Moderna completes FDA submission for use of COVID shot in adolescents, kids
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 022 M - -
Net income 2022 11 474 M - -
Net cash 2022 18 522 M - -
P/E ratio 2022 5,08x
Yield 2022 -
Capitalization 54 855 M 54 855 M -
EV / Sales 2022 1,65x
EV / Sales 2023 3,26x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 137,91 $
Average target price 225,18 $
Spread / Average Target 63,3%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-45.70%54 855
LONZA GROUP AG-27.63%40 862
IQVIA HOLDINGS INC.-26.03%39 504
SEAGEN INC.-12.27%24 966
ICON PUBLIC LIMITED COMPANY-31.87%17 153
CELLTRION, INC.-26.77%15 702